Isolated hypertriglyceridemia: An insulin-resistant state with or without low HDL cholesterol

Journal of Atherosclerosis and Thrombosis

Volumn 13, Issue 3, 2006, Pages 143-148

  Al Mahmood, A K ^a   Ismail, Aziz Al Safi ^b   Rashid, F A ^a   Wan Mohamed, W B ^a  

^a SCHOOL OF PHYSICS   (Malaysia)

^b SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Homeostasis model assessment (HOMA); Insulin secretory status; Insulin sensitivity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; COMPUTER PROGRAM; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTOR; SECRETION;

ADULT; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTORS; SOFTWARE;

EID: 33749047287     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.13.143     Document Type: Article

References (24)

1. Mafauzy M, Mokhtar N, Wan Mohamad WB, and Musalmah M: Diabetes mellitus and associated cardiovascular risk factors in North-East Malaysia. Asia Pac J Public Health, 1999; 11:16-19.
2. Nawawi HM, Nor IM, Noor IM, Karim NA, Arshad F, Khan R, et al: Current status of coronary risk factors among rural Malays in Malaysia. Journal of Cardiovascular Risk, 2002; 9:17-23.
3. Mustapha BE: Diabetes epidemic in Malaysia. Med J Malaysia, 2004; 59:295.
4. Karhapaa P, Malkki M, and Laakso M: Isolated low HDL cholesterol: An insulin-resistant state. Diabetes, 1994; 43:411-417.
5. National Cholesterol Education Program (NCEP): Expert Panel on Detection, Evaluation and treatment of High Blood Cholesterol in Adults (Adult treatment panel III): Executive summary of the third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and treatment of High Blood Cholesterol in Adults (Adult treatment panel III). Circulation, 2001; 106.
6. Boden G: Pathogenesis of type 2 diabetes. Endocrinology and Metabolism Clinics of North America, 2001; 30:801-813.
7. Ministry of Health Malaysia: Malaysian Guidelines for Good Clinical Practice, 1999.
8. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 2002; 20:1183-1197.
9. Meigs JB, Wilson PW, Nathan DM, D'Agostino RBSr, Williams K, and Haffher SM: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham offspring studies. Diabetes, 2003; 52:2160-2167.
10. Ford ES and Giles WH: A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diab Care, 2003; 26:575-581.
11. Ministry of Health Malaysia: Clinical Practice Guideline on Management of Hypertension, 2002.
12. Friedewald WT: Estimation of serum low density lipoprotein. Clin Chem, 1972; 18:499.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC: Homeostasis model assessment: insulin resistance and beta-cell filriction from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28:412-419.
14. Hosker JP, Rudenski AS, Burnett MA, Matthews DR, and Turner RC: Similar reduction of first and second phase B-cell response at three different glucose levels in type II diabetes and the effect of gliclizide therapy. Metabolism, 1989; 38:767-772.
15. Rudenski AS, Matthews DR, Levy JC, and Turner RC: Understanding "insulin resistance" both glucose resistance and insulin resistance are required to model human diabetes. Metabolism, 1991; 40:908-917.
16. Hermans MP, Levy JC, Morris RJ, and Turner RC: Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia, 1999; 42:678-687.
17. SPSS Inc.: Statistical Package for Social Sciences software for Windows, release 11.1 Chicago: SPSS Inc 2000.
18. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al: Prevalence of insulin resistance in metabolic disorders: The Bruneck study. Diabetes, 1998; 47:1643-1649.
19. McKane WR, Stevens AB, Woods R, Andrews WJ, Henry RW, and Bell PM: The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metabolism, 1990; 39:1240-1245.
20. Sum CF, Wang KW, Tan CE, Fok KC, Chew LS, and Tan YT: Hyperinsulinemia in non-obese subjects with hypertriglyceridemia: a preliminary report. Ann Acad Med Singapore, 1992; 21:10-13.
21. Moro E, Gallina P, Pais M, Cazzolato G, Alessandrini P, and Bittolo-Bon G: Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with the 1999 World Health Organization criteria of classification of diabetes. Metabolism, 2003; 52:616-619.
22. Karhapaa P, Malkki M, and Laakso M: Isolated low HDL Cholesterol: An Insulin-Resistant state. Diabetes, 1994; 43:411-417.
23. Tai ES, Emmanuel SC, Chew SK, Tan BY, and Tan CE: Isolated low HDL cholesterol: an-insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes, 1999; 48:1088-1092.
24. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, and Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in community study): a cohort study. Lancet, 1999; 353:1649-1652.